Filing Details

Accession Number:
0000899243-21-036599
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-09-20 17:00:50
Reporting Period:
2021-09-16
Accepted Time:
2021-09-20 17:00:50
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1690585 Magenta Therapeutics Inc. MGTA Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1741286 Jason Gardner C/O Magenta Therapeutics, Inc.
100 Technology Square
Cambridge MA 02139
See Remarks No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-09-16 14,340 $6.73 286,872 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 292,990 Indirect By J.P. Gardner Irrevocable Trust
Common Stock 359,092 Indirect By P.S. Gardner Irrevocable Trust
Footnotes
  1. This transaction represents shares sold solely to pay taxes due upon the vesting of restricted stock units, as disclosed by the reporting person on the Form 4 filed on September 16, 2021.
  2. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.60 to $6.87, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.